Role of interferon γ and tumour necrosis factor α in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line
- 1 November 1992
- journal article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 34 (6) , 393-398
- https://doi.org/10.1007/bf01741750
Abstract
In view of cellular adoptive immunotherapy we have studied monocyte-mediated cytostasis and cytotoxicity against U 937 cells, a human histiocytic lymphoma cell line. Highly purified human monocytes and monocytederived macrophages were activated with interferon γ (IFN) or tumour necrosis factor α (TNF) to antileukemic immune effector cells. Antileukemic activity of human monocytes was dependent on monocyte differentiation into macrophages and on a dose- and time-dependent activation with IFN or TNF. Maximum cytostasis of 97.0±0.7% (mean ± SEM) (conventional [3H]dT uptake assay) and 81.9±5.3% cytotoxicity (modified MTT assay) of U 937 cells was obtained by monocytes activated with 100 U/ml IFN for at least 24 h at an effector-to-target-cell ratio of 10. U 937 cells premodified with IFN showed an increase in susceptibility to monocyte-mediated cytotoxicity. U 937 cells premodified with TNF were almost resistant to monocyte-mediated cytotoxicity while activated monocytes maintained their cytotoxic potential. These data show that IFN and TNF are potent activators of monocyte-mediated cytotoxicity. Furthermore, IFN and TNF might be involved in the regulation of the susceptibility of leukemic cells to lysis by interactions with monocytes or macrophages.Keywords
This publication has 44 references indexed in Scilit:
- Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinationsInternational Journal of Cancer, 1990
- Tumor-associated macrophagesCurrent Opinion in Immunology, 1990
- Human monocyte tumouristatic ability: Modulation by cytokines and tumour cell productsInternational Journal of Immunopharmacology, 1990
- Adoptive cancer immunotherapy utilizing lymphokine activated killer cells and gamma interferon activated killer monocytesPharmacology & Therapeutics, 1988
- Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transferEuropean Journal of Cancer and Clinical Oncology, 1988
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferonNature, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Potential Pitfalls of [3H]Thymidine Techniques to Measure Cell ProliferationCell Proliferation, 1981